Clover Health Investments (CLOV) Receivables - Other (2020 - 2024)
Clover Health Investments (CLOV) has disclosed Receivables - Other for 5 consecutive years, with $15.0 million as the latest value for Q3 2024.
- For the quarter ending Q3 2024, Receivables - Other rose 1.37% year-over-year to $15.0 million, compared with a TTM value of $15.0 million through Sep 2024, up 1.37%, and an annual FY2023 reading of $16.7 million, up 3233.2% over the prior year.
- Receivables - Other was $15.0 million for Q3 2024 at Clover Health Investments, down from $21.2 million in the prior quarter.
- Across five years, Receivables - Other topped out at $24.3 million in Q1 2023 and bottomed at $500000.0 in Q4 2022.
- Average Receivables - Other over 5 years is $17.0 million, with a median of $16.7 million recorded in 2023.
- The sharpest move saw Receivables - Other tumbled 96.5% in 2022, then skyrocketed 3233.2% in 2023.
- Year by year, Receivables - Other stood at $11.4 million in 2020, then increased by 25.63% to $14.3 million in 2021, then crashed by 96.5% to $500000.0 in 2022, then surged by 3233.2% to $16.7 million in 2023, then decreased by 10.22% to $15.0 million in 2024.
- Business Quant data shows Receivables - Other for CLOV at $15.0 million in Q3 2024, $21.2 million in Q2 2024, and $22.5 million in Q1 2024.